Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

8.83

+0.12 (1.38%)

At close: Aug 14, 2026, 4:00 PM EDT

8.90

+0.07 (0.79%)

After-hours: Aug 14, 2026, 7:36 PM EDT

Puma Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	456	300	150	206	196	124
Market Cap Growth	70.71%	100.26%	-27.32%	5.07%	57.73%	-69.53%
Enterprise Value	367	246	139	233	233	154
Last Close Price	8.83	5.95	3.05	4.33	4.23	3.04

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.53	9.64	4.95	9.54	98021.07	-
Forward PE	30.45	12.55	11.62	10.57	33.92	127.84
PS Ratio	1.97	1.31	0.65	0.87	0.86	0.49
PB Ratio	3.26	2.30	1.63	3.85	9.07	-50.81
P/TBV Ratio	4.47	3.37	3.65	-	-	-
P/FCF Ratio	11.07	7.19	3.85	7.67	-	6.02
P/OCF Ratio	11.08	7.17	3.85	7.63	-	6.02
PEG Ratio	-	25.68	25.68	25.68	25.68	25.68

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.59	1.08	0.61	0.99	1.02	0.61
EV/EBITDA Ratio	9.14	5.20	3.39	5.44	5.74	12.22
EV/EBIT Ratio	12.05	6.61	4.50	7.14	7.58	119.32
EV/FCF Ratio	8.91	5.91	3.59	8.68	-	7.45

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.04	0.22	0.80	2.09	5.29	-47.69
Debt / EBITDA Ratio	0.11	0.56	1.66	2.33	2.54	6.78
Debt / FCF Ratio	0.12	0.68	1.91	4.15	-	5.65
Net Debt / Equity Ratio	-0.64	-0.53	-0.29	0.29	1.54	-14.12
Net Debt / EBITDA Ratio	-2.22	-1.45	-0.65	0.36	0.82	2.74
Net Debt / FCF Ratio	-2.16	-1.65	-0.69	0.58	-2.10	1.67
Asset Turnover	1.19	1.06	1.04	1.04	1.02	1.08
Inventory Turnover	5.31	8.17	8.15	10.80	9.47	12.06
Quick Ratio	2.57	1.86	1.38	1.45	1.59	1.05
Current Ratio	2.91	2.00	1.54	1.57	1.73	1.28
Return on Equity (ROE)	21.97%	27.97%	41.60%	57.54%	0.02%	-
Return on Assets (ROA)	9.81%	10.85%	8.72%	9.01%	8.56%	0.34%
Return on Invested Capital (ROIC)	56.55%	51.23%	46.14%	50.21%	0.16%	1.04%
Return on Capital Employed (ROCE)	21.30%	27.60%	26.40%	24.90%	21.20%	1.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.86%	10.38%	20.22%	10.48%	0.00%	-23.43%
FCF Yield	9.03%	13.92%	25.96%	13.04%	-8.07%	16.61%
Buyback Yield / Dilution	-3.62%	-3.16%	-3.26%	-5.83%	-10.56%	-2.69%

SEC Filings: 10-K · 10-Q